Publication & Citation Trends
Publications
0 total
Correction: The deubiquitylase USP9X controls ribosomal stalling OA
Cited by 3
Semantic Scholar
Author response: USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma OA
Cited by 0
Semantic Scholar
Abstract 2334: Discovery of selective inhibitors of carbamoyl phosphate synthetase I (CPS1) to modulate cancer relevant metabolic pathways
Cited by 0
Semantic Scholar
Discovery of Aminopyrazole Derivatives as Potent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3. OA
Cited by 14
Semantic Scholar
Discovery of 2,6-Dimethylpiperazines as Allosteric Inhibitors of CPS1. OA
Cited by 7
Semantic Scholar
Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket. OA
Cited by 35
Semantic Scholar
The deubiquitylase USP9X controls ribosomal stalling OA
Cited by 34
Semantic Scholar
USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylation OA
Cited by 102
Semantic Scholar
Research Topics
Cytokine Signaling Pathways and Interactions
(36)
Mathematical Biology Tumor Growth
(22)
Chronic Myeloid Leukemia Treatments
(10)
Ubiquitin and proteasome pathways
(8)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(8)
Affiliations
Forma Therapeutics (United States)
AstraZeneca (Brazil)
AstraZeneca (United States)
Rockefeller University Press
Imperial College London